phase ii trial of acu193 in alzheimer’s disease
Published 6 months ago • 137 plays • Length 4:21Download video MP4
Download video MP3
Similar videos
-
9:17
phase ii trial of xpro1595 for the treatment of alzheimer’s disease
-
4:23
phase ii trial of ar1001 as a potential treatment for alzheimer’s disease
-
1:12
new alzheimer's disease clinical trial: acu193 for alzheimer's disease
-
7:25
acu193 in alzheimer's disease: insights from the intercept ad study
-
6:34
phase iia exploratory trial of t3d-959 in mild-moderate alzheimer’s disease
-
6:17
preliminary results from the phase ii pioneer trial of t3d-959 in mild-moderate alzheimer’s disease
-
18:06
phase ii/iii gain trial results: atuzaginstat for disease modification in alzheimer’s disease
-
1:31
phase ii study of lecanemab in early ad
-
2:46
phase ii/iii gain trial of a novel lysine-gingipain inhibitor for the treatment of alzheimer’s
-
1:57
phase iii ahead 3-45 trial of lecanemab for preclinical alzheimer’s disease
-
1:38
the potential of lecanemab for the treatment of early alzheimer’s disease
-
7:14
phase iii admet2 trial of methylphenidate for apathy in alzheimer's disease
-
4:36
phase iib elad trial of liraglutide in mild-moderate alzheimer’s disease
-
1:08
prevention strategies for alzheimer’s disease
-
4:22
improving clinical trials for alzheimer’s disease therapies
-
1:52
the future of sage-718 in alzheimer’s disease treatment
-
2:39
nir lipsman discusses a phase 2 alzheimer's disease trial in toronto
-
1:54
what’s next for clinical trials in alzheimer’s disease?
-
2:35
inmune bio phase 2 clinical trial of xpro in alzheimer's disease